1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon: International Agency for Research on Cancer. 2013.
http://globocan.iarc.fr
. Accessed 13 Aug 2014.
2. Kraywinkel K, Bertz J, Laudi A, Wolf U. Epidemiologie und Früherkennung häufiger Krebserkrankungen in Deutschland. GBEkompakt. Berlin: Robert Koch-Institut; 2012.
3. Luengo-Fernandez R, Leal J, Gray A, Sullivan R. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol. 2013;14(12):1165–74. doi:
10.1016/s1470-2045(13)70442-x
.
4. Popiolek M, Rider JR, Andrén O, Andersson S-O, Holmberg L, Adami H-O, et al. Natural history of early, localized prostate cancer: a final report from three decades of follow-up. Eur Urol. 2013;63(3):428–35.
http://dx.doi.org/10.1016/j.eururo.2012.10.002
.
5. Mottet N, Bastian PJ, Bellmunt J, Van den Bergh RC, Bolla M, Van Casteren NJ, et al. Guidelines on prostate cancer. 2014.